ViiVConnect Programs

Eligible Medications

ViiVConnect is available to help you with questions on CABENUVA (cabotegravir; rilipivirine) Patient Savings Program, ViiVConnect Savings Card, ViiV Healthcare Patient Assistance Program (PAP), or other topics relating to helping patients get their prescribed ViiV Healthcare medications. Click on the tabs below to learn more about eligible ViiV Healthcare medications.

  • DOVATO

    (dolutegravir and lamivudine)

    id-card

    ViiVConnect Savings Card*

    Tablets: 50 mg dolutegravir and 300 mg lamivudine

     

    Up to $6250 per year with no monthly limit

    Patient Assistance
    Program (PAP)*

    Tablets: 50 mg dolutegravir and 300 mg lamivudine

    Expand for eligible programs

    JULUCA

    (dolutegravir and rilpivirine)

    id-card

    ViiVConnect Savings Card*

    Tablets: 50 mg dolutegravir and 25 mg rilpivirine

     

    Up to $6250 per year with no monthly limit

    Patient Assistance
    Program (PAP)*

    Tablets: 50 mg dolutegravir and 25 mg rilpivirine

    Expand for eligible programs

    LEXIVA

    (fosamprenavir calcium)

    id-card

    ViiVConnect Savings Card*

    Tablets: 700 mg
    Oral Suspension: 50 mg/mL

     

    Up to $4800 per year with no monthly limit

    Patient Assistance
    Program (PAP)*

    Tablets: 700 mg
    Oral Suspension: 50 mg/mL

    Expand for eligible programs

    RETROVIR

    (zidovudine)

    id-card

    ViiVConnect Savings Card*

    Injection, for intravenous use:
    10 mg/mL (20 mL vial)

     

    Up to $4800 per year with no monthly limit

    Patient Assistance
    Program (PAP)*

    Capsules: 100 mg
    Oral Solution: 10 mg/mL
    Injection, for Intravenous use: 
    10 mg/mL (20 mL vial)

    Expand for eligible programs

    RUKOBIA

    (fostemsavir)

    id-card

    ViiVConnect Savings Card*

    Extended-Release Tablets: 600 mg

     

    Up to $7500 per year with no monthly limit

    Patient Assistance
    Program (PAP)*

    Extended-Release Tablets: 600 mg

    Expand for eligible programs

    SELZENTRY

    (maraviroc)

    id-card

    ViiVConnect Savings Card*

    Tablets: 25 mg

    Tablets: 300 mg

    Tablets: 75 mg

    Oral Solution:

    Tablets: 150 mg

    20 mg/mL

     

    Up to $4800 per year with no monthly limit

    Patient Assistance
    Program (PAP)*

    Tablets: 25 mg

    Tablets: 300 mg

    Tablets: 75 mg

    Oral Solution:

    Tablets: 150 mg

    20 mg/mL

    Expand for eligible programs

    TIVICAY

    (dolutegravir)

    id-card

    ViiVConnect Savings Card*

    Tablets: 10 mg
    Tablets: 25 mg
    Tablets: 50 mg

     

    Up to $5000 per year with no monthly limit

    Patient Assistance
    Program (PAP)*

    Tablets: 10 mg
    Tablets: 25 mg
    Tablets: 50 mg

    Expand for eligible programs

    TIVICAY PD

    (dolutegravir)

    id-card

    ViiVConnect Savings Card*

    Tablets for Oral Suspension: 5 mg

     

    Up to $5000 per year with no monthly limit

    Patient Assistance
    Program (PAP)*

    Tablets for Oral Suspension: 5 mg

    Expand for eligible programs

    TRIUMEQ

    (abacavir, dolutegravir, and lamivudine)

    id-card

    ViiVConnect Savings Card*

    Tablets: 600 mg abacavir, 50 mg dolutegravir, and 300 mg lamivudine

     

    Up to $7500 per year with no monthly limit

    Patient Assistance
    Program (PAP)*

    Tablets: 600 mg abacavir, 50 mg dolutegravir, and 300 mg lamivudine

    Expand for eligible programs

    TRIZIVIR

    (abacavir, lamivudine, and zidovudine)

    id-card

    ViiVConnect Savings Card*

    Tablets: 300 mg abacavir, 150 mg lamivudine, and 300 mg zidovudine

     

    Up to $4800 per year with no monthly limit

    Patient Assistance
    Program (PAP)*

    Tablets: 300 mg abacavir, 150 mg lamivudine, and 300 mg zidovudine

    Expand for eligible programs

    VIRACEPT

    (nelfinavir mesylate)

    id-card

    ViiVConnect Savings Card*

    Tablets: 250 mg nelfinavir free base
    Tablets: 625 mg nelfinavir free base

     

    Up to $4800 per year with no monthly limit

    Patient Assistance
    Program (PAP)*

    Tablets: 250 mg nelfinavir free base
    Tablets: 625 mg nelfinavir free base

    Expand for eligible programs

    ZIAGEN

    (abacavir)

    id-card

    ViiVConnect Savings Card*

    Oral Solution: 20 mg/mL

     

    Up to $4800 per year with no monthly limit

    Patient Assistance
    Program (PAP)*

    Tablets: 300 mg
    Oral Solution: 20 mg/mL

    Expand for eligible programs

    Subject to eligibility, program terms, and conditions. ViiVConnect programs do not constitute health insurance.

    Total savings not to exceed $7500 per year. Restrictions apply. Offer limited to 1 per person.

     

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

  • CABENUVA (cabotegravir; rilipivirine) Patient Savings Program

    CABENUVA

    (cabotegravir; rilpivirine)

    Patient Savings Program*

    Extended-release injectable suspensions: cabotegravir 200 mg/mL; rilpivirine 300 mg/mL

     

    Up to $13,000 per year

    Patient Assistance
    Program (PAP)

    Extended-release injectable suspensions: cabotegravir 200 mg/mL; rilpivirine 300 mg/mL

    Expand for eligible programs

    CABENUVA Patient Savings Program is subject to eligibility and is not health insurance.

    CABENUVA Patient Savings Program helps eligible enrolled patients with their out-of-pocket costs for CABENUVA for up to $13,000 every calendar year. Medicare-eligible patients and patients enrolled in government-funded programs are not eligible for CABENUVA Patient Savings Program.

     

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

  • Patient Assistance Program (PAP)

    CABENUVA

    (cabotegravir; rilpivirine)

    Patient Assistant Program (PAP)*

    Extended-release injectable suspensions: cabotegravir 200 mg/mL; rilpivirine 300 mg/mL

    Patient Savings Programs

    Extended-release injectable suspensions: cabotegravir 200 mg/mL; rilpivirine 300 mg/mL

    Up to $13,000 per year

    Expand for eligible programs

    COMBIVIR

    (lamivudine and zidovudine)

    Patient Assistant Program (PAP)*

    Tablets: 150 mg lamivudine and 300 mg zidovudine

    DOVATO

    (dolutegravir and lamivudine)

    Patient Assistant Program (PAP)*

    Tablets: 50 mg dolutegravir and 300 mg lamivudine

    ViiVConnect Savings Card*

    Tablets: 50 mg dolutegravir and 300 mg lamivudine
    Up to $6250 per year with no monthly limit

    Expand for eligible programs

    EPIVIR

    (lamivudine)

    Patient Assistant Program (PAP)

    Tablets: 150 mg

    Tablets: 300 mg

    Oral Solution: 10 mg/ mL

    EPZICOM

    (abacavir and lamivudine)

    Patient Assistant Program (PAP)

    Tablets: 600 mg abacavir and 300 mg lamivudine

    JULUCA

    (dolutegravir and rilpivirine)

    Patient Assistant Program (PAP)

    Tablets: 50 mg dolutegravir and 25 mg rilpivirine

    ViiVConnect
    Savings Card*

    Tablets: 50 mg dolutegravir and 25 mg rilpivirine
    Up to $6250 per year with no monthly limit

    Expand for eligible programs

    LEXIVA

    (fosamprenavir calcium)

    Patient Assistant Program (PAP)

    Tablets: 700 mg
    Oral Suspension: 50 mg/mL

    ViiVConnect
    Savings Card*

    Tablets: 700 mg
    Oral Suspension: 50 mg/mL

     

    Up to $4800 per year with no monthly limit

    Expand for eligible programs

    RETROVIR

    (zidovudine)

    Patient Assistant Program (PAP)

    Capsules: 100 mg
    Oral Solution: 10 mg/mL
    Injection, for Intravenous use:
    10 mg/mL (20 mL vial)

    ViiVConnect
    Savings Card*

    Injection, for Intravenous use:
    10 mg/mL (20 mL vial)

     

    Up to $4800 per year with no monthly limit

    Expand for eligible programs

    RUKOBIA

    (fostemsavir)

    Patient Assistant Program (PAP)

    Extended-Release Tablets: 600 mg

    ViiVConnect
    Savings Card*

    Extended-Release Tablets: 600 mg

     

    Up to $7500 per year with no monthly limit

    Expand for eligible programs

    SELZENTRY

    (maraviroc)

    Patient Assistant Program (PAP)

    Tablets: 25 mg

    Tablets: 300 mg

    Tablets: 75 mg

    Oral Solution:

    Tablets: 150 mg

    20 mg/mL

    ViiVConnect
    Savings Card*

    Tablets: 25 mg

    Tablets: 300 mg

    Tablets: 75 mg

    Oral Solution:

    Tablets: 150 mg

    20 mg/mL

     

    Up to $4800 per year with no monthly limit

    Expand for eligible programs

    TIVICAY

    (dolutegravir)

    Patient Assistant Program (PAP)

    Tablets: 10 mg
    Tablets: 25 mg
    Tablets: 50 mg

    ViiVConnect
    Savings Card*

    Tablets: 10 mg
    Tablets: 25 mg
    Tablets: 50 mg

     

    Up to $5000 per year with no monthly limit

    Expand for eligible programs

    TIVICAY PD

    (dolutegravir)

    Patient Assistant Program (PAP)

    Tablets for Oral Suspension: 5 mg

    ViiVConnect
    Savings Card*

    Tablets for Oral Suspension: 5 mg

     

    Up to $5000 per year with no monthly limit

    Expand for eligible programs

    TRIUMEQ

    (abacavir, dolutegravir, and lamivudine)

    Patient Assistant Program (PAP)

    Tablets: 600 mg abacavir, 50 mg dolutegravir, and 300 mg lamivudine

    ViiVConnect
    Savings Card*

    Tablets: 600 mg abacavir, 50 mg dolutegravir, and 300 mg lamivudine

     

    Up to $7500 per year with no monthly limit

    Expand for eligible programs

    TRIZIVIR

    (abacavir, lamivudine, and zidovudine)

    Patient Assistant Program (PAP)

    Tablets: 300 mg abacavir, 150 mg lamivudine, and 300 mg zidovudine

    ViiVConnect
    Savings Card*

    Tablets: 300 mg abacavir, 150 mg lamivudine, and 300 mg zidovudine

     

    Up to $4800 per year with no monthly limit

    Expand for eligible programs

    VIRACEPT

    (nelfinavir mesylate)

    Patient Assistant Program (PAP)

    Tablets: 250 mg nelfinavir free base
    Tablets: 650 mg nelfinavir free base

    ViiVConnect
    Savings Card*

    Tablets: 250 mg nelfinavir free base
    Tablets: 650 mg nelfinavir free base

     

    Up to $4800 per year with no monthly limit

    Expand for eligible programs

    ZIAGEN

    (abacavir)

    Patient Assistant Program (PAP)

    Tablets: 300 mg
    Oral Solution: 20 mg/mL

    ViiVConnect
    Savings Card*

    Oral Solution: 20 mg/mL

     

    Up to $4800 per year with no monthly limit

    Expand for eligible programs

    Subject to eligibility, program terms, and conditions. ViiVConnect programs do not constitute health insurance.

    CABENUVA Patient Savings Program helps eligible enrolled patients with their out-of-pocket costs for CABENUVA for up to $13,000 every calendar year. Medicare-eligible patients and patients enrolled in government-funded programs are not eligible for CABENUVA Patient Savings Program.

    Total savings not to exceed $7500 per year. Restrictions apply. Offer limited to 1 per person.

     

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

MRVWCNT210015